Today on Health in 2 Point 00, Jess and I cover all the deals that got overshadowed by the big news of Teladoc and Livongo’s merger. First up is Ginger, the mental health provider which raised $50 million in a D round bringing their total up to $120 million. Infermedica, an AI enabled symptom checker and triage tool, raised $10.25 million in a series A. Next, Xealth landed a $6 million investment from Cerner and LRVHealth, partnering with Cerner and bringing their digital health prescribing tool to Cerner in addition to its current integration with Epic. Finally SOC Telemed is going public through a “reverse” merger with Healthcare Merger Corp. —Matthew Holt



from The Health Care Blog https://ift.tt/30BRL3F

Related Posts:

  • Don’t want my age revealed…By LISA SUENNEN & MATTHEW HOLT Yesterday it was Fortune’s 40 under 40, and a lot of great people, most of whom I thought were much older or at least seem to have been around a while, got listed in the health care section–… Read More
  • The Wrong LegaciesBy KIM BELLARD I read two articles this week that got me thinking, Robert Charette’s “Inside the Hidden World of Legacy IT Systems” (IEEE Spectrum) and Douglas Holt’s “Cultural Innovation” (Harvard Business Review).  … Read More
  • A New Kind of Labor Day By KIM BELLARD This is probably the strangest Labor Day in decades, perhaps ever.   Tens of millions of workers remain unemployed due to the COVID-19 pandemic.  Many of those who are still working are adapti… Read More
  • The COVID-19 Symptom Data Challenge WebinarBy INDU SUBAIYA & FARZAD MOSTASHARI Following the launch of the COVID-19 Symptom Data Challenge on September 1st, we are excited to host a dedicated webinar providing further insights into the Challenge directly from key… Read More
  • Why Primary Care Should Run the Healthcare SystemBy KEN TERRY (This is the fourth in a series of excerpts from Terry’s new book, Physician-Led Healthcare Reform: a New Approach to Medicare for All, published by the American Association for Physician Leadership.) Many oth… Read More

0 comments:

Post a Comment

Popular Posts